SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001570562-18-000037
Filing Date
2018-05-10
Accepted
2018-05-10 16:26:58
Documents
47
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q evolus03311810-q.htm 10-Q 1042226
2 EXHIBIT 31.1 exhibit31103311810q.htm EX-31.1 14971
3 EXHIBIT 31.2 exhibit31203311810q.htm EX-31.2 15159
4 EXHIBIT 32.1 exhibit32103311810q.htm EX-32.1 7908
  Complete submission text file 0001570562-18-000037.txt   3737691

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT eols-20180331.xml EX-101.INS 455291
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eols-20180331.xsd EX-101.SCH 27785
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT eols-20180331_cal.xml EX-101.CAL 41663
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT eols-20180331_def.xml EX-101.DEF 184249
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eols-20180331_lab.xml EX-101.LAB 389741
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eols-20180331_pre.xml EX-101.PRE 258134
Mailing Address 17901 VON KARMAN AVENUE, SUITE 150 IRVINE CA 92614
Business Address 17901 VON KARMAN AVENUE, SUITE 150 IRVINE CA 92614 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38381 | Film No.: 18822936
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences